Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Heffner

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Pageof 7